Officer and Director Transaction - Mirza Mansoor Raza

Mirza Mansoor Raza, Chief Medical Officer of Acrivon Therapeutics, Inc. (ACRV), acquired 38,817 shares of Common Stock on May 18, 2026. The acquisition was made at a price of $0.00 per share. These shares represent restricted stock units (RSUs) that vest over time, with a portion vesting on November 18, 2026, and the remainder in subsequent quarterly installments, subject to continuous service.